Skip to content
Research Article Open access CC BY 4.0

The Role of Mesenchymal Stem Cells Secretome in Regeneration of Thyroid Tissue Damage after Thyroid Lobectomy: A Literature Review

Joko Wibowo Sentoso, Agung Putra, Henky Agung Nugroho

Journal of Cancer and Tumor International · pp. 14–20 · Published 11 May 2024

10.9734/jcti/2024/v14i2252

Abstract

Mesenchymal Stem Cells (MSC) are a type of stem cell that is multipotent and originates from the mesoderm and ectoderm at an early stage of development and can differentiate into: 1. Ectodermal derivatives such as: neurons, keratocytes and keratinocytes; 2. Endodermal derivatives such as: hepatocytes and pancreatic β cells. MSCs were first discovered in the bone marrow, but in recent research they have been found in many other body tissues, such as the lungs, pancreas, liver, adipose tissue, synovial tissue, muscles, bones, amniotic fluid and umbilical cord blood. MSCs vary in content, accessibility, proliferation ability, immunomodulatory capacity, and the cytokines they secrete, and have different therapeutic potential based on different sources. Recent evidences showed that even the secreted factor including secretome, microvesicles, or exosomes alone without the cell may repair damaged tissue in various conditions. In this review, we summarize the latest research which aims to provide an overview of the influence of the mesenchymal stem cells secretome in regenerating damaged follicular thyroid tissue after thyroid lobectomy, so that in the future research can be carried out on this matter to minimize complications after thyroid lobectomy, can even regenerate follicular thyroid tissue, and can be an option treatment to help overcome the current challenges of hormone replacement therapy.

Mesenchymal stem cells mesenchymal stem cells secretome follicular thyroid nodule thyroid lobectomy

References (28)

  1. 1 Mesenchymal stem cells as trophic mediators [DOI]
  2. 2 Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells [DOI]
  3. 3 Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease [DOI]
  4. 4 Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy [DOI]
  5. 5 Mesenchymal stem cell exosomes [DOI]
  6. 6 Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications [DOI]
  7. 7 Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation [DOI]
  8. 8 Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction [DOI]
  9. 9 Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine [DOI]
  10. 10 Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair [DOI]
  11. 11 The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease [DOI]
  12. 12 Different Sources of Mesenchymal Stem Cells for Tissue Regeneration: A Guide to Identifying the Most Favorable One in Orthopedics and Dentistry Applications [DOI]
  13. 13 Hemithyroidectomy: A Meta-Analysis of Postoperative Need for Hormone Replacement and Complications [DOI]
  14. 14 The developmental basis of mesenchymal stem/stromal cells (MSCs) [DOI]
  15. 15 Mesenchymal stem/stromal cells (MSCs): origin, immune regulation, and clinical applications [DOI]
  16. 16 Mesenchymal stem cell-derived secretome and microvesicles as a cell-free therapeutics for neurodegenerative disorders [DOI]
  17. 17 Extracellular Vesicles: Immunomodulatory messengers in the context of tissue repair/regeneration [DOI]
  18. 18 Recent Advances in Mesenchymal Stem Cell Immunomodulation: The Role of Microvesicles [DOI]
  19. 19 Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study [DOI]
  20. 20 Peripheral blood mononuclear cell secretome for tissue repair [DOI]
  21. 21 Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction [DOI]
  22. 22 Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium [DOI]
  23. 23 Exosome: A Novel and Safer Therapeutic Refinement of Mesenchymal Stem Cell [DOI]
  24. 24 Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features [DOI]
  25. 25 Thyroid Regeneration: How Stem Cells Play a Role? [DOI]
  26. 26 Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease [DOI]
  27. 27 Stem Cell Therapy for Thyroid Diseases: Progress and Challenges [DOI]
  28. 28 Basic Molecular Stem Cell

Cited by 2

2 citations reported by external sources — individual citing-article records aren't available to list yet.

Related research

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.